NAKSHATHRA MEDISCIENCE PVT LTD

CIDRAP DAILY NEWS

COVID-19 long-haulers—even those who experienced mild cases—are at significantly increased risk for substantial declines in kidney function, such as organ damage and chronic and end-stage kidney disease (ESKD), according to a study today in the Journal of the American Society of Nephrology.

WHO MEDIA

WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases.

IDSA NEWSLETTER

A recent study in Antimicrobial Agents and Chemotherapy compared combination therapy consisting of a ß-lactam plus an aminoglycoside with ß-lactam monotherapy in hematological neutropenic patients with gram-negative bloodstream infections.

Welcome to Nakshathra Medi Science

Nakshathra Medi Science Pvt Ltd is a super specialty pharmaceutical company with a clear vision and aim to build up a strong presence in Critical Care, Intensive care Neurology, Nephrology, Urology and Nutraceuticals. We will Establish the organisation in ethical and scientific path, with its corporate office based in Chennai. NMSPL is dedicated in serving quality medicines for a healthier lifestyle.

CIDRAP DAILY NEWS

WHO MEDIA

IDSA NEWSLETTER

Welcome to Nakshathra Medi Science

Our Product

ANTIMICROBIALS

ESSDIUM

Ampitem 1. 5

Amipitem 3

Cefebac

Clinbac

Doxybacter

Imecarb

Pipzum

Polwin

Sustin 2

Sustin 3

Zepime

Merlact

MINERAL SUPPLEMENTS

Essdium

Zirich

OSMOTIC DIURETIC

Natol

VITAMIN INJECTABLES

Corbik

contact us

Address

Mobile - Email

Office Contact: